[{"arm_notes": "", "treatment_id": null, "treatment_name": "Biological/Vaccine; Non-Stem Cell : Low dose of GC5131; intermediate dose of GC5131; high dose of GC5131 (each 2500mg; 5000mg; 10000mg); once; iv;If a subject were assigned into an each intervention group; prepare the number of assigned intervention vials. If assigned into placebo group; prepare 50 mL saline.Start infusion at 0.01 to 0.02 mL/kg/min (e.g.; 0.6 to 1.2 mL / min with a body weight of 60 kg) for 30 minutes; gradually increasing to0.06 for remainder of infusion.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "2500mg", "treatment_id": 540, "treatment_name": "Gc5131", "treatment_type": "Immunoglobulins", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "5000mg", "treatment_id": 540, "treatment_name": "Gc5131", "treatment_type": "Immunoglobulins", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "10000mg", "treatment_id": 540, "treatment_name": "Gc5131", "treatment_type": "Immunoglobulins", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]